Eagle Pharmaceuticals
EGRX
#10303
Rank
C$15.32 M
Marketcap
C$1.18
Share price
0.00%
Change (1 day)
28.38%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: C$15.32 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of C$15.32 Million. This makes Eagle Pharmaceuticals the world's 10303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$15.32 M91.93%
2025C$7.98 M-21.92%
2024C$10.22 M-88.65%
2023C$90.08 M-82.55%
2022C$0.51 B-38.4%
2021C$0.83 B8.31%
2020C$0.77 B-27.66%
2019C$1.06 B40.06%
2018C$0.76 B-23.8%
2017C$1.00 B-39.26%
2016C$1.65 B-14.21%
2015C$1.92 B661.76%
2014C$0.25 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
C$15.32 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$733.06 B 4,782,838.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$135.60 B 884,687.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$385.38 B 2,514,390.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
C$50.70 B 330,715.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$247.57 B 1,615,220.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.295 T 8,451,316.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$156.53 B 1,021,242.55%๐Ÿ‡บ๐Ÿ‡ธ USA